| Property | Value |
|---|
|
?:abstract
|
-
The outbreak of COVID-19 caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) that has created huge trepidation worldwide, has a mortality rate of 0.5-1% which is growing incessantly. There are currently no therapies and/or vaccines that may help to abate this viral disease but the use of masks and social distancing can limit the spread. Boosting immunity has been a simple way to resist viral infection and limit fatalities. In this context, the use of nutraceuticals appears to be a potential panacea. The ability of algae-based nutraceuticals, mainly Spirulina for boosting immunity against viral diseases has already been reported clinically. Spirulina-based nutraceuticals boost the adaptive and innate immunity, and bioactive compounds such as ACE inhibitor peptides, phycobiliproteins, sulfated polysaccharides, and calcium-spirulan can serve as antiviral agents. The presence of these molecules indicates its potential role in resisting infection and the COVID-19 disease progression. This review focuses on the potential role of algal nutraceuticals as immune boosters for combating human coronavirus and other viral diseases. The potential use of Spirulina-based nutraceuticals for combating COVID-19, its mechanism, and future directions have also been discussed.
|
|
is
?:annotates
of
|
|
|
?:creator
|
|
|
?:doi
|
|
|
?:doi
|
-
10.1016/j.nut.2020.111089
|
|
?:journal
|
|
|
?:license
|
|
|
?:pdf_json_files
|
-
document_parses/pdf_json/013a2a45f448f6ad3d9d57c85e32263dc1b723a1.json
|
|
?:pmc_json_files
|
-
document_parses/pmc_json/PMC7680017.xml.json
|
|
?:pmcid
|
|
|
?:pmid
|
|
|
?:pmid
|
|
|
?:publication_isRelatedTo_Disease
|
|
|
is
?:relation_isRelatedTo_publication
of
|
|
|
?:sha_id
|
|
|
?:source
|
|
|
?:title
|
-
Prospectives of algae derived nutraceuticals as supplements for combating COVID-19 and human coronavirus diseases
|
|
?:type
|
|
|
?:year
|
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}